• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
74,253.50 270.32
( 0.37%)
Global Indices
Nasdaq
49,934.70 -958.41
(-1.88%)
Dow Jones
7,287.94 -119.71
(-1.62%)
Hang Seng
64,050.08 -129.19
(-0.20%)
Nikkei 225
10,254.58 27.25
(0.27%)
Forex
USD-INR
95.41 -0.12
(-0.12%)
EUR-INR
110.18 0.04
(0.03%)
GBP-INR
127.60 0.17
(0.13%)
JPY-INR
0.60 0.00
(-0.17%)

EQUITY - MARKET SCREENER

Advanced Enzyme Technologies Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
540025
INE837H01020
63.3737836
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
ADVENZYMES
30.93
4177.27
EPS(TTM)
Face Value()
Div & Yield %
12.06
2
0.36
 

mrf ltd
Zodiac Ventures consolidated net profit rises 133.33% in the March 2026 quarter
May 22,2026
Net profit of Zodiac Ventures rose 133.33% to Rs 0.63 crore in the quarter ended March 2026 as against Rs 0.27 crore during the previous quarter ended March 2025. Sales rose 200.00% to Rs 0.90 crore in the quarter ended March 2026 as against Rs 0.30 crore during the previous quarter ended March 2025.

For the full year,net profit rose 52.48% to Rs 1.54 crore in the year ended March 2026 as against Rs 1.01 crore during the previous year ended March 2025. Sales rose 114.38% to Rs 3.43 crore in the year ended March 2026 as against Rs 1.60 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales0.900.30 200 3.431.60 114
OPM %37.78276.67 -67.35218.75 -
PBDT0.710.31 129 2.001.20 67
PBT0.690.29 138 1.931.14 69
NP0.630.27 133 1.541.01 52